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Ocular surface inflammation associated with Sjo¨gren’s syndrome is characterized by a loss of secretory function and alteration in
numbers of mucin secreting goblet cells. Such changes are a prominent feature of ocular surface inflammatory diseases and are
attributed to inflammation; however, the exact effect of the inflammatory cytokines on conjunctival goblet cell function remains
largely unknown. In this study, we developed a primary culture of mouse goblet cells from conjunctival tissue and evaluated
the effects on their function by inflammatory cytokines detected in the conjunctiva of mouse model of Sjo¨gren’s syndrome
(Thrombospondin-1 deficient mice). We found that apoptosis of goblet cells was primarily induced by TNF-𝛼 and IFN-𝛾. These
two cytokines also inhibited mucin secretion by goblet cells in response to cholinergic stimulation, whereas IL-6 enhanced such
secretion. No changes in secretory response were detected in the presence of IL-13 or IL-17. Goblet cells proliferated to varying
degrees in response to all the tested cytokines with the greatest response to IL-13 followed by IL-6. Our results therefore reveal
that inflammatory cytokines expressed in the conjunctiva during an ocular surface disease directly disrupt conjunctival goblet cell
functions, compromising the protective function of tears, thereby contributing to ocular surface damage.
1. Introduction
Mucin-secreting goblet cells are widely distributed through-
out mammalian mucosal surfaces, such as the gastrointesti-
nal, urogenital, and respiratory tracts, where they play a key
role in hydrating, lubricating, and clearing pathogens from
the underlying epithelium [1]. The importance of goblet cells
as major producers of mucins is well established, with critical
emphasis placed on the number of functional goblet cells and
on the amount and rate at which they synthesize mucins. In
fact, alterations in goblet cell numbers and mucin secretion
are prominent features of mucosa associated diseases, with
increased goblet cell numbers and hypersecretion in con-
ditions such as asthma or cystic fibrosis [2, 3], and mucin
depletion and diminished goblet cell density in intestinal
diseases such as inflammatory bowel disease or ulcerative
colitis [4, 5].
In the eye, goblet cells are the principal secretory cell
in the conjunctival epithelium, where they function in
lubricating the ocular surface epithelia during the blink res-
ponse stabilizing the tear film, and as a physical barrier to
pathogen penetration [6]. Alterations in goblet cell secretion
lead to an unstable tear film and a vulnerable ocular surface.
Goblet cell loss has been reported in several inflammatory
diseases of the ocular surface, including Stevens-Johnson
syndrome, ocular mucous membrane pemphigoid, alkali
burn, neutrophilic keratitis, graft-versus-host-disease, and
Sjo¨grens’s syndrome (SS) [7–9].
Although the mechanisms leading to goblet cell changes
in the eye are not entirely understood, evidence in othermuc-
osal tissues suggests that inflammation may have an impor-
tant contribution. It is known that IL-13 is involved in lung
goblet cell hyperplasia and mucus hypersecretion [10], while
IFN-𝛾 inhibited IL-13-induced goblet cell hyperplasia in a
mouse model of airway inflammation [11] and it is a potent
inhibitor of mucin secretion in a human colonic goblet
cell line [12]. Although both IL-13 and IFN-𝛾 have been
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reported in ocular inflammatory conditions it is not known
whether conjunctival goblet cells respond similarly to those
in the lungs with mucus hypersecretion or with inhibition
of secretion [13, 14]. It was also previously reported that
overexpression of IL-17A induces respiratory mucous meta-
plasia [15]. However, the role of inflammation in conjunctival
goblet cell function has remained unaddressed, partly due to
lack of in vitro cell cultures that allow study of goblet cells
without altering their phenotype and function.Therefore, we
have developed a primary culture of mouse goblet cells from
conjunctival tissue to evaluate the effects of inflammatory
cytokines on goblet cells with respect to processes such as
mucin secretion, proliferation, and apoptosis.
We have previously described extensively an autoium-
mune SS-associated ocular phenotype inThrombospondin-1
(TSP-1) deficient mice that resembles the changes detectable
in SS patients [16]. These mice spontaneously and progres-
sively develop inflammation in the conjunctiva, with appear-
ance of inflammatory infiltrates, tissue expression of Th1 and
Th17 inflammatory cytokines, along with the development of
inflammatory T cell effectors in their draining lymph nodes
[17]. Similar to SS patients, significant changes in goblet cell
numbers are detected in TSP-1 deficient mice along with
reduced tear mucin level.
Our primary purpose in this study was to evaluate
whether inflammation in TSP-1 deficient conjunctiva dis-
rupts the functions of goblet cells. We used cultured goblet
cells from mouse conjunctiva to study the effect of inflam-
matory cytokines detected in TSP-1 null conjunctiva on
secretory and proliferative properties of goblet cells. The
studies described herein indicate that mouse goblet cells, as
shown previously with rat and human goblet cells [18, 19], can
be isolated from mouse conjunctiva retaining in vivo charac-
teristics of mouse goblet cells, and that the proinflammatory
cytokines expressed in TSP-1 null conjunctiva induce their
proliferation in varying degrees. Greatest proliferation was
induced by IL-13 with IL-6 following closely. Both TNF-𝛼 and
IFN-𝛾 induced goblet cell apoptosis while inhibiting mucin
secretion induced by cholinergic stimulation. Contrary to
this effect IL-6 enhanced such mucin secretion by goblet
cells. Our results therefore reveal that inflammation can
directly disrupt conjunctival goblet cell functions resulting in
an altered tear composition with a compromised protective
function, which contributes to ocular surface damage.
2. Materials and Methods
2.1. Mice. C57BL/6 (H-2b) mice, 4 to 22 weeks old, were pur-
chased from Charles River Laboratories (Wilmington, MA).
TSP-1 null mice (C57BL/6 background), originally received
fromDr. J. Lawler (BIDMC,HarvardMedical School, Boston,
MA) were bred in-house in a pathogen-free facility at Schep-
ens Eye Research Institute, Boston,MA.All experiments were
conducted in accordance with institutional guidelines and
ARVO Statement for the Use of Animals in Ophthalmic and
Vision Research.
2.2. RT-PCR. Total RNA was isolated from conjunctivas
harvested from WT or TSP-1 null mice (6, 8, and 12 weeks,
𝑛 = 3 to 5) using TRIzol Reagent (Life Technologies, Car-
lsbad, CA) according to the manufacturer’s instructions.
cDNA was synthesized by reverse transcribing RNA using
oligo (dT) and M-MLV RT (Promega, Madison, WI). Real-
time PCR assay was performed on the Eppendorf Real-
plex2 system (Eppendorf AG, Hamburg, Germany) using
SYBR Green PCR Master Mix (Applied Biosystems, Carl-
sbad, CA) to determine relative quantitative expression lev-
els of Interleukin (IL)-13 and GATA3 genes. IL-13 pri-
mers (F-5󸀠-AGAATGGCCTGTTACACTCA-3󸀠 and R-5󸀠-
TTTCCGGTTTCTAGTTTGA-3󸀠), GATA3 primers (F-5󸀠-
GCCTGGCGCCGTCTTGATA-3󸀠 and R-5󸀠-CCCGGTCAG-
ATTGCG TAGCTC-3󸀠), and glyceraldehyde-3-phosphate
dehydrogenase primers (F-5󸀠-CGAGAATGGGAAGCTTG-
TCA-3󸀠 and R-5󸀠-AGACACCAGTAGACTCCACGACAT-
3󸀠) were used. Amplification reactions were set up in qua-
druplicates with the thermal profile: 95∘C for three minutes,
40 cycles at 95∘C for ten seconds, 53∘C for ten seconds, and
72∘C for ten seconds. To verify the specificity of the ampli-
fication reaction, a melting curve analysis was performed.
Fluorescence signal generated at each cycle was analyzed
using system software. The threshold cycle values were used
to determine relative quantification of gene expression with
glyceraldehyde-3-phosphate dehydrogenase as a reference
gene.
2.3. Isolation and Culture of Goblet Cells. Goblet cells from
mouse conjunctival pieces were grown in organ culture,
as described previously for rat and humans [18, 19]. Con-
junctival tissues were excised from 4- to 22-week-old male
mice and placed into Hank’s balanced salt solution (Lonza,
Walkersville, MD). Tissues were finely minced into small
pieces that were anchored onto scored 24-well culture plates.
Approximately 65 to 90 explants were obtained from each
animal and four pieces of tissue were anchored per culture
well. The culture dishes contained just enough medium
to cover the bottom of the well so that the tissue would
receive nutrients through surface tension. Explants were
fed every other day with RPMI-1640 medium (Lonza,
Walkersville, MD) supplemented with 10% heat-inactivated
fetal calf serum (Thermo Fisher Scientific, Waltham, MA),
1mMsodiumpyruvate, 10mMHEPES, 100𝜇g/mLpenicillin-
streptomycin, and 1X nonessential amino-acid mixture
(Lonza, Walkersville, MD) and grown under routine culture
conditions of 5% CO
2
at 37∘C. Cells were permitted to
grow from the tissue explant for 14 days until reaching 85%
confluence; and then the explant was removed and discarded.
2.4. Immunofluorescence. Cultured conjunctival goblet cells
were fixed in ice-cold methanol and examined for the pres-
ence of cytokeratin (CK)-4, CK-7, and MUC5AC. Cells were
incubated at room temperature for one hour with blocking
buffer composed of phosphate-buffered saline (PBS) with 2%
bovine serum albumin and 0.02% Triton-X (all from Sigma-
Aldrich). Afterwards, the cells were incubated overnight
at 4∘C with the primary antibodies anti-CK-7 (10 𝜇g/mL),
which recognizes a goblet cell-specific keratin [20], anti-
CK-4 (10 𝜇g/mL), a specific marker for stratified, squamous,
nongoblet epithelial cells [20], and MUC5AC (2 𝜇g/mL),
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specific for mucin produced by goblet cells [21] (all from
Abcam, Cambridge, MA). After rinsing in PBS, the cells were
incubatedwithAlexaFluor 488- or 568-conjugated secondary
antibodies (6 𝜇g/mL; Life Technologies, Carlsbad, CA) for
one hour at room temperature, washed, and mounted for
microscopy examination in a Nikon Eclipse E-800 fluores-
cence microscope (Nikon, Melville, NY).
2.5. Flow Cytometry. Cultured conjunctival goblet cells were
stained with eFluor 780-conjugated Fixable Viability Dye
(eBioscience, San Diego, CA). Intracellular MUC5AC was
evaluated with anti-MUC5AC antibody (Abcam) and DyL-
ight 649-conjugated secondary antibody (Abcam) using an
intracellular staining kit (eBioscience) as per the manufac-
turer’s instructions. Fluorescence-labeled cells were analyzed
using BD LSRII Flow Cytometer (BD Bioscience, San Jose,
CA). Further analysis of the data was performed using FlowJo
v9.4.10 software (Tree Star, Inc., Ashland, OR).
2.6. Cytokine Treatments. To evaluate the effect of inflamma-
tory conditions on goblet cell function, cultured conjunctival
goblet cells were grown for 14 days until 85% confluence was
reached. Prior to any cytokine exposure, cells were main-
tained for 24 h in serum-free medium. After this, cultured
conjunctival goblet cells were treated with 10 ng/mL of the
recombinant cytokines IL-13, IFN-𝛾, TNF-𝛼, IL-6, and IL-
17A (R&D Systems, Minneapolis, MN) for 24 h. Viability of
cells in response to stimulatory cytokines (63% IL-13-treated,
66% in IL-6-treated) was comparable to that in response
to inhibitory cytokines (65% IFN-𝛾-treated, 71% TNF-𝛼-
treated) and untreated control cells (66%).
2.7. MUC5AC Secretion: ELISA. Treated and control cultures
of conjunctival goblet cells were stimulated with the cho-
linergic agonist carbachol (10−3M, Sigma-Aldrich) for one
hour and then MUC5AC secretion was measured in the sup-
ernatants using the Mucin-5 Subtype AC (MUC5AC) ELISA
kit (TSZ ELISA, Waltham, MA) according to the manufac-
turer’s instructions. The cells were also collected and cell
homogenates were analyzed for the total amount of protein
using the BCA Protein Assay Kit (Pierce, Rockford, IL).
MUC5AC secretion was normalized to total protein in the
homogenate, and the result was presented as MUC5AC
ng/mg of cellular protein.
2.8. Cell Proliferation and Apoptosis. Treated and control
cultured goblet cells were pulsed with the thymidine ana-
log, 5-bromo-2-deoxyuridine (BrdU, 1mM) (EMDMillipore,
Billerica, MA) for 24 h. Afterwards, the cells were fixed
and permeabilized using an intracellular staining kit (eBio-
science), treated with DNase (Sigma-Aldrich) to expose
incorporatedBrdUand stainedwith a biotin-conjugated anti-
BrdU antibody (1𝜇g/106 cells; Invitrogen) for one hour at 4∘C.
After rinsing in PBS, cells were incubated with streptavidin-
FITC-conjugated reagent (1 𝜇g/106 cells; BD Bioscience) for
one hour at 4∘C and stained with the DNA dye 7-amino-
actinomycin-D (7-AAD) (eBioscience). BrdU content (FITC)
and total DNA content (7-AAD) were determined using
BD LSRII Flow Cytometer and FlowJo software, and the
percentage of cells in each of the G
0
-G
1
, S, G
2
-M phases and
apoptotic cells were calculated.
2.9. Statistical Analysis. Student’s t-test was used to deter-
mine significant differences between mean values of exper-
imental and control groups. Error bars in figures represent ±
standard error of the mean (SEM). 𝑃 < 0.05 was considered
statistically significant.
3. Results
3.1. Th2 Inflammatory Response in TSP-1 Null Conjunctiva.
In human SS pathology a dynamic balance between Th1 and
Th2 cytokines was reported with the latter found to prevail
in low-grade infiltration of salivary glands [22]. Similarly
Th2-mediated pathology was reported in theMRL/lpr mouse
model of SS [23]. To determine if the spontaneous ocular
surface inflammation noted in TSP-1 deficient mice involves
Th2 cytokines, we examined conjunctival expression of the
transcription factor GATA-3, an essential mediator of these
cytokines. We also correlated this expression with that of a
representativeTh2 cytokine IL-13. Real-time PCR analysis on
RNA isolated from conjunctiva derived from WT or TSP-
1 null mice at ages 6, 8, and 12 weeks was performed to
study the expression levels of GATA-3 and IL-13. Although no
differences in GATA3 expression were detectable at 6 weeks
of age, at 8 and 12 weeks the expression was significantly
increased in TSP-1 deficient conjunctiva compared with the
WT control tissues (Figure 1(a)). Consistent with this result,
overexpression of IL-13 was detected in TSP-1 null conju-
nctiva at all ages compared to the aged-matched WT control
tissues (Figure 1(b)). Together these results suggest invo-
lvement of Th2-mediated pathology in the ocular surface
inflammation in TSP-1 null mice similar to that reported by
others in SS.
3.2. Primary Mouse Conjunctival Goblet Cell Culture. It has
been reported that IL-13 is involved in lung goblet cell
hyperplasia and mucus hypersecretion [10]. Increased expre-
ssion of IL-13 in TSP-1 null conjunctiva is consistent with
increased goblet cell numbers detected in the earlier stages
of ocular surface inflammation between 8 and 12 weeks of
age [16]. However, by 15 weeks of age a significant decline
in filled goblet cells is detected in TSP-1 null conjunctiva as
compared to age-matched WT controls [17]. To allow for an
investigation of a direct effect of conjunctival cytokines, if any,
on goblet cell proliferation ormucin secretion, we established
in vitro cultures of goblet cells derived from conjunctival
tissue explants based on a method originally described using
rat and human tissue [18, 19].
Cells were grown from WT conjunctival explants. After
14 days of culture, epithelial morphology of most of the cells
was apparent with the presence of distinct secretory gra-
nules. To determine if these were goblet cells extensive chara-
cterization with goblet cell-specific markers was performed.
These included goblet cell derived soluble mucin, MUC5AC,
and an intermediate filament associated solely with gob-
let cells, cytokeratin 7 (CK-7). Any presence of stratified
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Figure 1: Th2-type inflammatory response is increased in TSP-1 null conjunctiva. Conjunctiva tissues were collected from WT and TSP-1
null mice at 6, 8, and 12 weeks. Extracted RNA was analyzed in a real time PCR assay to determine the levels of message for theTh2 cytokine
IL-13 and theTh2-associated transcription factor GATA3 ∗𝑃 < 0.05.
squamous epithelial cells was ruled out by staining for their
marker cytokeratin 4 (CK-4). As seen in Figure 2(a), most
cells in culture stained positively for goblet cell specific mar-
kers MUC5AC and CK-7 with a detectable intense cytosolic
signal for both these markers. On the other hand, no signal
was detected when cells were stained for CK-4 resembling
the isotype control staining with no fluorescence signal. Fur-
thermore, flow cytometric analysis of cultured cells stained
for intracellular MUC5AC was performed to establish a qua-
ntitative estimate of goblet cells in the culture. As shown in
Figure 2(b), a strong signal was detected in positive control
HT-29 cell line as all the cells stained positively forMUC5AC,
and similarly most cells (>85%) from primary cultures were
positively stained forMUC5AC.These results confirmed that
almost all cells in our conjunctival explant-derived primary
cultures were goblet cells that can be further used in an in
vitro assay.
3.3. Deficiency of TSP-1 in Goblet Cells Does Not Alter Their
Ability to Secrete MUC5AC in Response to Cholinergic Stim-
ulation. Cultured goblet cells respond to in vitro cholinergic
stimulation induced by carbachol by releasing their vesicular
content of MUC5AC into the culture supernatant. In rat and
human goblet cell cultures this was determined using an
assay that detects glycosylated carbohydrates [18, 19].We used
MUC5AC ELISA to assess the secretory function of WT and
TSP-1 null goblet cells in primary cultures. These cells were
generated from either 4-week or 22-week-old mice. Upon
carbachol stimulation MUC5AC in the culture supernatant
was compared to that collected from unstimulated cells.
As shown in Figure 3, both 4-week-old WT and TSP-1
null conjunctiva-derived primary cultures of goblet cells
responded to carbachol stimulus by secreting significantly
increased amounts of MUC5AC in culture supernatants.
A similar response was noted in cultures generated from
22-week-old WT mice. However, such increased release
of MUC5AC was inhibited when goblet cell cultures were
derived from 22-week-old TSP-1 null mice, suggesting a
loss of their secretory ability. These results implicate active
ocular surface inflammation in older TSP-1 null mice as a
potential cause of the disrupted secretory function of goblet
cells.
3.4. Expression of Cytokine Receptors in Primary Cultures of
Conjunctival Goblet Cells. During ocular surface inflamma-
tion the conjunctival cytokine environment in TSP-1 null
mice includes Th1 (TNF𝛼, IFN𝛾) and Th17 (IL-17A, IL-6)
besides Th2 cytokines, and these are largely detectable by 6
weeks of age with a progressive increase by 12 weeks [17]. To
determine if these cytokines may inhibit the secretory func-
tion of TSP-1 null goblet cells as detected in our results, we
first assessed the presence of receptors for the cytokines that
were detected in TSP-1 null conjunctiva during ocular surface
inflammation. Cultured goblet cells from WT mice were
stained with immunofluorescence-conjugated antibodies for
the indicated receptors and stained cells were analyzed by
flow cytometry. Expression of each receptor was evaluated by
comparing mean fluorescence intensity (MFI) of the staining
with receptor-specific antibody to that of a corresponding
isotype control antibody. As shown in Figure 4, receptors
for all the cytokines tested were detectable on goblet cells
as indicated by the significantly increased receptor specific
MFI. These results suggest that cytokines such as IL-13,
IFN-𝛾, TNF-𝛼, IL-6, and IL-17 that are detectable during
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Figure 2: Primary mouse goblet cell cultures express goblet cell specific markers. (a) Cells were grown fromWT conjunctival explants for 14
days, and the expression of goblet cell specific (CK-7-red andMUC5AC-green) and stratified squamous cell specific (CK-4-red) markers was
analyzed by immunofluorescence. Nuclei were counterstained with DAPI (blue). Magnification = ×20. (b) Flow cytometric analysis of goblet
cells for the expression of MUC5AC. Unstained cells (empty histogram), isotype controls (filled grey histogram), colonic HT-29 cells (filled
green histogram), and cultured goblet cells (filled red histogram).
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Figure 3: Conjunctival inflammation associated with TSP-1 defi-
ciency prevents carbachol-mediated MUC5AC secretion. Cultured
goblet cells were grown from conjunctival explants ofWT and TSP-1
null mice at 4 and 22 weeks of age. Goblet cells were stimulated with
the cholinergic agonist carbachol, andMUC5AC secretion evaluated
by ELISA in the supernatant. ∗𝑃 < 0.05.
ocular surface inflammation in TSP-1 null mice have the
potential to influence goblet cells directly via their respective
receptors.
3.5. Inflammatory Cytokines Alter MUC5AC Secretion by
Goblet Cells in Response to Cholinergic Stimulation. To dete-
rmine if proinflammatory cytokines detected in TSP-1 null
conjunctiva may alter the secretory function of goblet cells,
we exposed goblet cell cultures derived from WT conjunc-
tiva explants to Th1 (IFN-𝛾 and TNF-𝛼), Th2 (IL-13), and
Th17 (IL-17A and IL-6) cytokines for 24 hr, prior to their
cholinergic stimulationwith carbachol. As shown in Figure 5,
carbachol-mediated mucin secretion of goblet cells exposed
to both Th1 cytokines (IFN-𝛾 and TNF-𝛼) was significantly
reduced as compared to those secreted by untreated cells.
In contrast carbachol-induced secretion was significantly
enhanced if cells were treated with IL-6. Carbachol stimula-
tion of IL-17A or IL-13 exposed goblet cells did not alter their
mucin secretion in comparison to untreated goblet cells.
These results suggest that during ocular inflammation,
presence of Th1 cytokines in the tissue environment could
directly inhibit goblet cell secretory function. These results
are consistent with reduced levels of MUC5AC detected in
pilocarpine-induced tears (cholinergic stimulation) collected
from TSP-1 null mice with ocular surface inflammation as
compared to those from WT control mice [17]. Together,
our results suggest that in an inflammatory environment in
TSP-1 null conjunctiva the inhibitory effects of Th1 cytokines
predominate over the enhancing effect of IL-6 on goblet cell
secretory function.
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Figure 4: Expression of cytokine receptors in primary cultures of
conjunctival goblet cells. The expression of the cytokine receptors
IL-13R𝛼1, IFN-𝛾RI, TNF-𝛼R1, TNF-𝛼R2, IL-6R𝛼, and IL-17RA was
detected using flow cytometry in primary cultures of conjunctival
goblet cells. Results are presented as mean fluorescence intensity
(MFI) for the cytokine receptors (black bars) and the corresponding
isotype controls (white bars). ∗𝑃 < 0.05.
3.6. Inflammatory Cytokines Alter Goblet Cell Proliferation
and Apoptosis. Changes in goblet cell numbers in TSP-1
null mice range from a significant increase during the early
stages of ocular inflammation between 8 and 12 weeks to a
significant decline with the disease progression by 15 weeks of
age [16, 17]. Similar changes are reported in the conjunctiva
of SS patients [24, 25]. The basis of these observed changes
in goblet cell numbers remains unclear especially since the
densities are determined based on the mucin content of
goblet cells as detected by Alcian Blue and Periodic Acid
Schiff (AB/PAS) staining. It is not clear whether the increase
in the number of goblet cells is due to inhibitedmucin release
or actual proliferation of these cells. Similarly, it remains
unclear whether the loss of goblet cells represents a mere
inability to detect them by AB/PAS staining after complete
release of their mucin content or whether the cell loss is due
to cell death.
To address some of these possibilities we evaluated pro-
liferation and apoptotic cell death in goblet cells treated with
selected cytokines. We treated goblet cell cultures derived
from WT conjunctiva explants with Th1 (IFN-𝛾 or TNF-
𝛼), Th2 (IL-13), and Th17 (IL-17A or IL-6) cytokines and
pulsed these cultures with BrdU, as described in methods.
Nuclear incorporation of BrdU was detected using fluores-
cence conjugated anti-BrdU antibody in combination with
vital dye 7-AAD. Flow cytometric staining pattern of BrdU
and 7-AAD was examined to identify cell cycle stages. Gates
were set to identify and enumerate proliferating cells (S +
G
2
), resting cells (G
0
+ G
1
), and apoptotic cells. As shown in
Figure 6(a), among goblet cells exposed to IL-13 as compared
with untreated cultures, a more than twofold increase in
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Figure 5: Inflammatory cytokines alter carbachol-mediated MUC5AC secretion by goblet cells. Cultured goblet cells were treated for 24 h
with IFN-𝛾, TNF-𝛼, IL-6, or IL-17A (10 ng/mL), stimulated with the cholinergic agonist carbachol (10−3M) for 1 h, and MUC5AC secretion
in the supernatants was evaluated by ELISA. ∗𝑃 < 0.05.
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Figure 6: Inflammatory cytokines alter proliferation and apoptosis rate of cultured conjunctival goblet cells. Cultured goblet cells were pulsed
with BrdU and treated for 24 h with 10 ng/mL of IL-13, IFN-𝛾, TNF-𝛼, IL-6, or IL-17A. Cells stained with fluorescence-conjugated anti-BrdU
antibody and viability dye 7-AAD was analyzed by flow cytometry to identify stages of cell cycles. (a) Representative flow cytometry plots are
shown and percentage of cells in each of the G
0
-G
1
, S + G
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-M phases and apoptotic cells are indicated for untreated control and IL-13 treated
cells. (b) Bar graphs show changes in proliferation (S + G
2
-M phases) and apoptosis relative to untreated controls.
proliferating cells (6.13% versus 2.71%) was detected with
nearly a threefold reduction in apoptotic cells (5.26% versus
15.1%). These results are consistent with the role of IL-13
described in the differentiation and proliferation of goblet
cells in other tissues [10, 26]. Contrary to such an effect of
the Th2 cytokine, as shown in Figure 4(b), a relatively lesser
degree (<twofold) of proliferation was detected among goblet
cells treated with Th1 cytokines (IFN-𝛾: 3.54% and TNF-𝛼:
4.56% versus 2.71%), which was however, accompanied with
increased apoptotic cells (IFN-𝛾: 30.1% and TNF-𝛼: 19.8%
versus 15.1%). These results are consistent with the inhibitory
effect of Th1 cytokines detected on mucin secretion of goblet
cells. The effect of Th17 cytokines resembled that of IL-13
in that an increased proportion of proliferating goblet cells
(IL-6: 5.95% and IL-17A: 4.87% versus 2.71%) with reduced
apoptotic cells (IL-6: 4.53% and IL-17A: 3.55% versus 15.1%)
were detected.
Together our results suggest that inflammatory cytokines
indeed alter proliferation as well as apoptosis of conjunc-
tival goblet cells in that increased expression of IL-13 and
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IL-6 in the conjunctiva may contribute to an initial increase
in goblet cell numbers (as seen in TSP-1 null mice) by
inducing their proliferation, while goblet cell loss may be
attributed toTh1 cytokines that cause their apoptosis. Further
investigation is needed to determine whether the inhibitory
effect of cytokines on goblet cellmucin secretion leads to their
apoptotic cell death.
4. Discussion
Ocular surface inflammation in TSP-1 deficient mice is
characterized by tissue expression of Th1, Th17, and Th2
cytokines and loss of secretory function with alteration
in numbers of mucin secreting goblet cells [17]. In this
present study, we developed a primary culture of mouse
goblet cells from conjunctival tissue and evaluated the effects
of inflammatory cytokines on goblet cells with respect to
processes such as mucin secretion, proliferation, and apop-
tosis. We demonstrated that inflammation has an essential
role in the disruption of conjunctival goblet cell functions,
and that the proinflammatory cytokines expressed in TSP-1
null conjunctiva induced significant changes in proliferation,
apoptosis, and mucin secretion of these cells.
In our experiments Th1 cytokines IFN-𝛾 and TNF-𝛼
inhibited cholinergic stimulus induced mucin secretion and
led to goblet cell apoptosis. Significantly increased expression
for these cytokines is detectable in TSP-1 deficient con-
junctiva as compared to WT tissues, and this expression
progressively increases with age similar to that of IL-13 [17].
Such increase was also accompanied with reducedMUC5AC
levels in tears secreted in response to cholinergic stimulation
in TSP-1 null mice compared to age-matched WT controls.
In SS patients, overexpression of both Th1 cytokines is noted
in the conjunctiva, which is also correlated with a decline in
goblet cell numbers [27, 28]. Similar decline in goblet cells
is also detected in TSP-1 null conjunctiva [17]. Thus, our in
vitro findings are consistent with in vivo results and hence
support a role for Th1 cytokines in inflammation-mediated
conjunctival goblet cell loss during SS. Furthermore, inhi-
bition of mucin secretion by these cytokines also explains
reduced tear MUC5AC detected in TSP-1 null mice as well
as SS patients [17, 29]. The inhibitory and proapoptotic effect
of IFN-𝛾 and TNF-𝛼 in conjunctival goblet cells are similar
to that reported in airway goblet cells [30, 31]. However, these
reports are based on mucous staining of the cells and do not
address secretory aspects of mucins. Studies that examined
mucous secretion from intestinal colonic goblet cell lines
reported stimulatory effect of IFN-𝛾 and TNF-𝛼 on mucin
secretion [32, 33]. These results differ from our observations
that address stimulatedmucin secretion as against basal levels
examined in colonic goblet cells. Furthermore, differential
effect of these cytokines on intestinal epithelial apoptosis was
reported with its induction by TNF-𝛼 but not IFN-𝛾 [34].
These results clearly indicate tissue specific differences in
responses to inflammatory cytokines.
Chronic inflammatory responses in many autoimmune
diseases, including SS, involve Th17 cytokines IL-17 and IL-
6 [35–38]. Increased mucin expression by airway epithelial
cells exposed to these cytokines in vitro was correlated
with the mucus hypersecretion detected in chronic airway
diseases [3]. In our experiments, while both IL-6 and IL-17
induced proliferation of conjunctival goblet cells, only IL-6
enhanced mucin secretion induced by cholinergic stimulus.
Considering reduced tear MUC5AC levels in TSP-1 null
mice, our in vitro results suggest that the stimulatory effect
of IL-6 is likely countered by some inhibitory signal in
vivo. Temporal analysis of TSP-1 deficient conjunctiva has
indicated significantly increased expression of TNF-𝛼 and
IFN-𝛾 until 12 weeks of age [17]. Therefore, possibly the
inhibitory effects of the latter two cytokines predominate
over stimulatory effects of IL-6. It is also possible that goblet
cell proliferation in response to Th17 cytokines represents a
mechanism to replenish lost goblet cells in the conjunctiva.
The relative expression of cytokines and tear MUC5AC levels
at later stages of the disease may provide further insights into
chronic inflammatory processes in Sjo¨gren’s pathology.
The expression of the representative Th2 cytokine IL-
13 was detected in exocrine gland and peripheral blood
mononuclear cells from patients with primary SS [22, 39].
Consistent with these reports, our results also point to an
involvement ofTh2-mediated pathology in the ocular surface
inflammation in TSP-1 null mice, with increased expression
of the Th2-associated transcription factor GATA3 and the
inflammatory cytokine IL-13 in TSP-1 null conjunctiva. The
effects of IL-13 on goblet cell hyperplasia have been exten-
sively studied in the gastrointestinal and respiratory tracts. It
is known to induce airway goblet cell differentiation, hyper-
plasia, and mucus hypersecretion in different inflammatory
diseases [10]. In the intestinal epithelium, mucin (MUC5AC)
secretion induced by IL-13 is critical for worm expulsion
during enteric nematode infections [40, 41]. Although the
effect of IL-13 on regulation of conjunctival goblet cell density
is not completely understood, the fact that IL-13 deficient
mice have a significantly lower number of filled conjunctival
goblet cells than wild type mice [42] suggested a potential
role of IL-13 in regulating conjunctival goblet cells. In this
study, we show that IL-13 has a direct effect on stimulating
conjunctival goblet cell proliferation without affecting their
mucin secretion. Increased expression of IL-13 in TSP-1 null
conjunctiva coincides with an initial increase in goblet cell
numbers between 8 and 12 weeks of age prior to their decline
[16].This change is also concurrent with significantly reduced
tear MUC5AC levels in TSP-1 null mice [17]. Together our
results indicate that although conjunctival goblet cells may
resemble airway goblet cells in their hyperplastic response to
IL-13, this proliferation may not be accompanied by mucin
hypersecretion in tears.
Goblet cell density is a critical parameter that reflects the
overall health of the ocular surface [43]. Alterations in mucin
secretion and goblet cell number are prominent features of
ocular surface diseases [7–9]. The information about the
mechanisms leading to goblet cell changes is limited, because
it is often extrapolated from studies using whole conjunctival
tissue. Goblet cell cultures derived from airway epithelia of
hamsters, rats, and humans have been in use for several
years in addition to colonic neoplastic cell lines [44–48],
but tissue specific differences among goblet cells cannot
be overlooked. Unlike conjunctival mucosa, goblet cells in
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the lungs are not abundant under normal conditions but are
induced by a variety of inflammatory stimuli to differentiate
them from pulmonary epithelial cell type, Clara cells [49]. In
the gastrointestinal mucosa goblet, cell numbers and mucin
secretion are modulated by intestinal and colonic microbes
[50]. No equivalent alterations in conjunctival goblet, cells
have been noted as yet.
Shatos et al. reported the first conjunctival goblet cell
culture, achieving the isolation and growth of goblet cells
from rat and human conjunctiva [18, 19]. Our study demon-
strates that conjunctival goblet cells can be also isolated from
mouse conjunctiva using the same explant culture system,
retaining goblet cell specific markers and functional activity.
This culture serves as an in vitro model to study the effect
of inflammation on goblet cells in a direct, controlled, and
reproducible manner.
5. Conclusion
This study demonstrates that inflammatory cytokines associ-
atedwith the ocularmanifestation of Sjo¨gren’s syndrome con-
tribute to the pathology by inducing apoptosis and altering
mucin secretion and proliferation of conjunctival goblet cells.
In addition, this study demonstrates successful and consistent
generation of mouse conjunctival goblet cell primary culture
for in vitro studies.
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